ANVS +24% on “data cleaning” PR: https://finance.yahoo.com/news/annovis-bio-provides-data-announcement-113000202.html Annovis Bio, Inc...today announced successful completion of data cleaning for its phase II/III study of buntanetap in patients with mild to moderate Alzheimer’s disease (AD). Topline efficacy data is expected in April.Caveat emptor.